EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00636155 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped funding

Conditions

Lymphoma, Small Lymphocytic
Leukemia, Lymphocytic, Chronic

Interventions

DRUG: cenersen sodium
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

David Rizzieri

Collaborators

[object Object]